Ying Huang
Welcome,         Profile    Billing    Logout  
 10 Trials 
18 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Huang, Ying G
DCAP, NCT04868565: Target Weaning Oxygen to Determine Cafffeine Duration for AOP

Completed
4
310
RoW
Caffeine Citrate 20 MG/1 ML Intravenous Solution [CAFCIT]
Children's Hospital of Chongqing Medical University
Apnea of Prematurity, Caffeine, Weaning Oxygen, Medicine Regimen
10/23
10/23
NCT04999228: Top Down Versus Step up in Pediatric Ulcerative Colitis

Recruiting
4
40
RoW
Infliximab, 5-ASA, AZA, Corticosteroids
Children's Hospital of Fudan University
Ulcerative Colitis, Infliximab, Children
06/25
12/26
NCT04999241: Combined Application of EEN in the Induction of Remission in PUC

Not yet recruiting
4
40
NA
exclusive enteral nutrition, corticosteroids, infliximab, 5-ASA, AZA, regular food
Children's Hospital of Fudan University
Exclusive Enteral Nutrition, Ulcerative Colitis, Children
10/26
12/27
NCT05043870: Combined Immunosuppression for Pediatric Crohn's Disease

Recruiting
4
128
RoW
Infliximab and immunosuppressives, IFX, IMMs, AZA, MTX, Infliximab, IFX
Children's Hospital of Fudan University
Crohn Disease, Infliximab, Immunosuppression, Children, Only
10/25
12/25
NCT04779320 / 2020-004301-31: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Recruiting
3
120
Europe, Canada, Japan, US, RoW
Vedolizumab IV, ENTYVIO, KYNTELES, MLN0002
Takeda, Takeda Development Center Americas, Inc.
Crohn's Disease (CD)
11/24
11/24
MLN0002-3024, NCT04779307 / 2020-004300-34: A Study of Vedolizumab in Children and Teenagers with Moderate to Severe Ulcerative Colitis (UC)

Active, not recruiting
3
121
Europe, Canada, Japan, US, RoW
Vedolizumab, MLN0002, ENTYVIO, KYNTELES
Takeda, Takeda Development Center Americas, Inc.
Colitis, Ulcerative
08/25
08/25
NCT05442567 / 2021-000630-34: A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

Recruiting
3
240
Europe, Canada, Japan, US, RoW
Vedolizumab IV, MLN0002, ENTYVIO, KYNTELES, No Intervention
Takeda, Takeda Development Center Americas, Inc.
Ulcerative Colitis, Crohn's Disease
08/31
08/31
EMBARK, NCT04524390 / 2020-000974-22: Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Completed
2
75
Europe, US, RoW
Maralixibat, Formerly LUM001 and SHP625, Placebo
Mirum Pharmaceuticals, Inc.
Biliary Atresia
11/23
02/24
NCT03968575: Sub-threshold Micro-Pulse Laser Therapy for Drusen of Dry AMD

Recruiting
N/A
20
RoW
laser treatment
The Eye Hospital of Wenzhou Medical University
Drusen
04/21
04/22
NCT04605536: Effect of Animation Video on the Success Rate of Children Swallowing Capsule Endoscopy

Completed
N/A
200
RoW
animation videos, explanation about endoscopy endoscopy
Children's Hospital of Fudan University
Capsule Endoscopy
10/23
10/23
NCT03725878: Effectiveness of Comprehensive Tertiary Interventions on Incidence and Clinical Outcomes of Birth Defects

Active, not recruiting
N/A
4808
RoW
Standard tertiary interventions of birth defects, Routine preconception and pregnant health cares, Additional preconception health care, Individualized guide for folic acid supplementary, Additional health care procedures during and after pregnancy, Green channels for antenatal care and postnatal care
Children's Hospital of Fudan University, Minhang Maternal and Children Health Hospital, Songjiang Maternal and Children Health Hospital
Birth Defects
10/23
09/24
OMICS_CODE_01, NCT06356545: Phenotype and Multi-omics Analysis of Children With Congenital Diarrhea and Enteropathy in China

Recruiting
N/A
60
RoW
Children's Hospital of Fudan University
Diarrhea Infantile
04/26
10/26
NCT06382519: Thalidomide Therapy for VEOIBD

Recruiting
N/A
40
RoW
Thalidomide
Children's Hospital of Fudan University
Inflammatory Bowel Diseases
12/25
12/26
TEECH-01, NCT05915325: Physical Training for Elderly Cancer Patients With Cachexia

Recruiting
N/A
49
RoW
Physical training
National Cheng-Kung University Hospital, National Cheng Kung University
Geriatric Assessment, Cancer, Cancer Cachexia
01/25
01/26
P1-SDBDC, NCT05580653: Phase 1 Seattle Dietary Biomarkers Development Center

Recruiting
N/A
30
US
Controlled feeding study of beef and/or pinto beans, Controlled feeding study of eggs and/or black beans
Marian Neuhouser, United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA), University of Nebraska, University of Washington, Duke University
Healthy Adults
02/25
08/25
NCT04528303: Whole Genome Sequencing Versus Whole Exome Sequencing for Congenital Diarrhea and Enteropahty

Recruiting
N/A
180
RoW
Whole genome sequencing, Whole exome sequencing
Children's Hospital of Fudan University
Diarrhea, Infantile, Enteropathy
10/25
12/25
P2-SDBDC, NCT06656338: Phase 2 Seattle Dietary Biomarkers Development Center

Not yet recruiting
N/A
30
US
Higher HEI-2020 diet followed by lower HEI-2020 diet, Lower HEI-2020 diet followed by higher HEI-2020 diet
Marian Neuhouser, United States Department of Agriculture - National Institute of Food and Agriculture (USDA-NIFA), University of Nebraska, University of Washington, Duke University
Healthy Adults
02/26
10/26
NCT03365609: A Comparison of Four Different Treatment Regimens of Helicobacter Pylori in Chinese Children

Recruiting
N/A
1440
RoW
triple therapy, sequential therapy, bismuth quadruple therapy, concomitant therapy
Ying HUANG, Guangzhou Women and Children's Medical Center, The Children's Hospital of Zhejiang University School of Medicine, Beijing Children's Hospital, Tang-Du Hospital
Helicobacter Infections
10/25
12/25

Download Options